Researcher at Royal Wolverhampton NHS Foundation Trust Has Published New Data on Inflammatory Bowel Disease (Ocular Manifestations of IBD: Pathophysiology, Epidemiology, and Iatrogenic Associations of Emerging Treatment Strategies).

A recent study published by a researcher at the Royal Wolverhampton NHS Foundation Trust in the United Kingdom explores the ocular manifestations of Inflammatory Bowel Disease (IBD). The study highlights that 4-12% of IBD patients experience ocular pathology, with Crohn's patients being more affected than those with ulcerative colitis. The research emphasizes the importance of integrated care between gastroenterology and ophthalmology to improve patient outcomes by detecting and managing ocular diseases early. The study also discusses the iatrogenic consequences of certain IBD treatments on the eyes, such as corticosteroids and methotrexate. [Extracted from the article]